The Proteomics Revolution: How AI-Driven Platforms and Strategic M&A are Redefining Drug Discovery and Diagnostics
The field of proteomics, the large-scale study of proteins and their functions, is experiencing a seismic shift. No longer a niche research tool, it is rapidly becoming the central engine for the next generation of drug development, diagnostics, and personalized healthcare. This transformation is being fueled by a potent convergence of staggering investment, strategic mergers